Obafemi Awolowo University
Also known as: Adeniyi Olagunju | Department of Clinical Pharmacy and Pharmacy Administration, Obafemi Awolowo University, Ile Ife Nigeria | Obafemi Awolowo University | Obafemi Awolowo University Hospitals Complex, Ile-Ife, Nigeria | Obafemi Awolowo University Ile Ife | Obafemi Awolowo University, Ile Ife | Obafemi Awolowo University, Ile Ife. Nigeria | Obafemi Awolowo University, Nigeria | Obafemi Awolowo University Teaching Hospital | Obafemi Awolowo University /Teaching Hospital, Ile- Ife, Osun State, Nigeria | Obafemi Awolowo University Teaching Hospitals | Obafemi Awolowo University Teaching Hospitals Complex | Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife
Highest phase reached
Phase 3
First clinical trial
Oct 1, 2013Last known activity
Jan 3, 2026
Timeline
1960s
- Jan 1, 1961
Obafemi Awolowo University— Founded
Drugs by trial phase (19 distinct, 10 trials)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (15 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Recent trials (25)
- NCT07303699Sponsor investigatorPhase 2Jan 3, 2026
- NCT07303699OfficialPhase 2Jan 3, 2026
- NCT07303699CollaboratorPhase 2Jan 3, 2026
- NCT07303699Lead sponsorPhase 2Jan 3, 2026
- NCT07022743Sponsor investigatorPhase 2Jul 1, 2025
- NCT07022743Lead sponsorPhase 2Jul 1, 2025
- NCT06532318Lead sponsorPhase 3Jul 24, 2024
- NCT06532318Sponsor investigatorPhase 3Jul 24, 2024
- NCT06199921Sponsor investigatorPhase 2Jan 3, 2024
- NCT06199921OfficialPhase 2Jan 3, 2024
- NCT06199921Lead sponsorPhase 2Jan 3, 2024
- NCT04771871CollaboratorPhase 2Apr 30, 2021
- NCT04721795Study directorPhase 2/Phase 3Jan 19, 2021
- NCT04721795Reponsible party - principal investigatorPhase 2/Phase 3Jan 19, 2021
- NCT04721795Lead sponsorPhase 2/Phase 3Jan 19, 2021
Details
- Founded
- Ife, NG Jan 1, 1961
- Last known activity
- Jan 3, 2026